Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study von Winner, Paul K., Blumenfeld, Andrew M., Eross, Eric J., Orejudos, Amelia C., Mirjah, Debbie L., Adams, Aubrey Manack, Brin, Mitchell F.

Volltext

OnabotulinumtoxinA treatment for chronic migraine reduces depression and anxiety in headache day frequency responders and nonresponders von Blumenfeld, Andrew M., Tepper, Stewart J., Robbins, Lawrence D., Orejudos, Amelia C., Adams, Aubrey Manack, Buse, Dawn C., Silberstein, Stephen D.

Volltext

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study von Blumenfeld, Andrew M., Stark, Richard J., Freeman, Marshall C., Orejudos, Amelia, Manack Adams, Aubrey

Volltext